Please use this identifier to cite or link to this item:
|Title:||A novel cyclic enkephalin analogue with potent opioid antagonist activity|
|Citation:||Weltrowska, G., Lu, Y., Lemieux, C., Chung, N.N., Schiller, P.W. (2004-09-20). A novel cyclic enkephalin analogue with potent opioid antagonist activity. Bioorganic and Medicinal Chemistry Letters 14 (18) : 4731-4733. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bmcl.2004.06.077|
|Abstract:||The synthesis and in vitro activity profile of a potent opioid peptide antagonist lacking an N-terminal amino group are described. 2′,6′- Dimethyl substitution of the Tyr 1 residue in opioid agonist peptides and deletion of the N-terminal amino group, as achieved by replacement of Tyr 1 with 3-(2,6-dimethyl-4-hydroxyphenyl)propanoic acid (Dhp), have been shown to produce opioid antagonists. To examine the effect of β-methylation of Dhp 1 in opioid peptides on the activity profile, stereoselective syntheses of (3S)- and (3R)-3-methyl-3-(2,6-dimethyl-4- hydroxyphenyl)propanoic acid [(3S)- and (3R)-Mdp] were carried out. In comparison with the cyclic parent antagonist peptide Dhp-c[D-Cys-Gly- Phe(pNO 2)-D-Cys]NH 2, the methylated analogue (3S)-Mdp-c[D-Cys-Gly-Phe(pNO 2)-D-Cys]NH 2 showed higher μ, δ and κ antagonist potencies in functional assays and higher binding affinities for μ, δ and κ opioid receptors (K i μ = 2.03 nM; K i δ = 2.34 nM; K i κ = 49.5 nM), whereas the corresponding (3R)-Mdp 1-analogue was less potent by 1-2 orders of magnitude. © 2004 Elsevier Ltd. All rights reserved.|
|Source Title:||Bioorganic and Medicinal Chemistry Letters|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on May 21, 2018
WEB OF SCIENCETM
checked on Apr 24, 2018
checked on May 4, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.